Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

586 articles

Research Review

Showing 1–3 of 3 articles · Keyword: Exosome Clear keyword

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V2026ResearchDrug Delivery

1. A multimodal anticancer strategy based on exosome-coated prussian blue nanocarriers for melanoma treatment

Roshani R, Ramezani M, Bagheri E, Alikhani M, Abnous K, Taghdisi Sm, Et Al.

Overcoming multidrug resistance and tumor recurrence in melanoma requires multimodal therapeutic strategies that surpass the limitations of monotherapy. Herein, we report a biomimetic nanoplatform, HMPB@EX-DOX, designed to combine chemotherapy, photothermal therapy (PTT), and iron-mediated oxidative stress to…

Read the article

International journal of nanomedicine2026ResearchNon-viral Gene DeliveryDrug Delivery

2. Engineered Natural Membrane Vesicle Exosomes as a Torin2 Delivery Platform for Targeted Therapy of Anaplastic Thyroid Carcinoma

Wang C, Zhang X, Qin G, Han P, Li Y, Wang X

Anaplastic thyroid carcinoma (ATC) is a highly aggressive malignancy with poor prognosis due to rapid progression and resistance to conventional therapies. Integrin αvβ3 is overexpressed in ATC, making it a promising target. Torin2, a potent mTOR inhibitor, shows antitumor activity but suffers from poor solubility…

Read the article

Nanotechnology2026ResearchDrug Delivery

3. Integrating Nanomaterials with Extracellular Vesicles: Engineering Strategies and Translational Perspectives

Le Th, Phan Lmt

Extracellular vesicles (EVs), particularly stem cell-derived exosomes, serve as vital natural nanocarriers in regenerative medicine, immune modulation, and targeted drug delivery due to their innate ability to transport bioactive cargo across complex biological barriers. Despite this potential, the therapeutic…

Read the article

Let's engineer the next delivery breakthrough together

We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through scale-up.

ResearchersRequest a technical consultationTalk formulation, characterisation or assay design with one of our scientists.Industry partnersExplore co-developmentFeasibility studies, co-development programmes and licensing.InvestorsExplore the market opportunitySourced market sizes, pipeline, investment and deal data for genetic medicine delivery.